Advertisement

PharmacoEconomics & Outcomes News

, Volume 817, Issue 1, pp 21–21 | Cite as

Liraglutide cost effective in type 2 diabetes with CV implications

Clinical study
  • 4 Downloads

Reference

  1. Shah D, et al. Cost-effectiveness and budget impact of liraglutide in type 2 diabetes patients with elevated cardiovascular risk: a US-managed care perspective. ClinicoEconomics and Outcomes Research 10: 791-803, 14 Nov 2018. Available from: URL: https://doi.org/10.2147/CEOR.S180067 CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations